A Phase 1, Open-Label, Randomized, Cross-Over Study to Evaluate the Effects of Multiple Doses of Erythromycin on the Pharmacokinetics of a Single Dose of Pregabalin Controlled Release in Healthy Subjects.

Trial Profile

A Phase 1, Open-Label, Randomized, Cross-Over Study to Evaluate the Effects of Multiple Doses of Erythromycin on the Pharmacokinetics of a Single Dose of Pregabalin Controlled Release in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Mar 2015

At a glance

  • Drugs Pregabalin (Primary) ; Erythromycin
  • Indications Bacterial infections; Epilepsy; Fibromyalgia; Postherpetic neuralgia
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 27 Jul 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Jun 2011 Planned end date changed from 1 Jun 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
    • 02 Jun 2011 Planned initiation date changed from 1 May 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top